CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-11-14 | EPIC INVESTMENTS, LLC 10% owner | Sale | −465,090 | $0.12 | $54K | 73,333,543 |
| 2013-11-11 | NARINE JEENARINE Director | Sale | −39,000 | $0.12 | $5K | 15,792,808 |
| 2013-11-11 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −39,000 | $0.12 | $5K | 21,535,048 |
| 2013-11-11 | EPIC PHARMA LLC 10% owner | Sale | −39,000 | $0.12 | $5K | 71,785,493 |
| 2013-11-11 | EPIC INVESTMENTS, LLC 10% owner | Sale | −39,000 | $0.12 | $5K | 71,785,493 |
| 2013-11-06 | NARINE JEENARINE Director | Sale | −122,200 | $0.12 | $15K | 16,235,699 |
| 2013-11-06 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −122,200 | $0.12 | $15K | 22,139,590 |
| 2013-11-06 | EPIC PHARMA LLC 10% owner | Sale | −122,200 | $0.12 | $15K | 73,798,633 |
| 2013-11-06 | EPIC INVESTMENTS, LLC 10% owner | Sale | −122,200 | $0.12 | $15K | 73,798,633 |
| 2013-10-29 | NARINE JEENARINE Director | Sale | −102,520 | $0.01 | $1K | 16,262,583 |
| 2013-10-29 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −139,800 | $0.13 | $18K | 22,176,250 |
| 2013-10-29 | EPIC PHARMA LLC 10% owner | Sale | −466,000 | $0.13 | $59K | 73,920,833 |
| 2013-10-29 | EPIC INVESTMENTS, LLC 10% owner | Sale | −466,000 | $0.13 | $59K | 73,920,833 |
| 2013-10-28 | NARINE JEENARINE Director | Sale | −102,300 | $0.13 | $13K | 16,365,103 |
| 2013-10-28 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −139,500 | $0.13 | $18K | 22,316,050 |
| 2013-10-28 | EPIC PHARMA LLC 10% owner | Sale | −465,000 | $0.13 | $60K | 74,386,833 |
| 2013-10-28 | EPIC INVESTMENTS, LLC 10% owner | Sale | −465,000 | $0.13 | $60K | 74,386,833 |
| 2013-09-10 | NARINE JEENARINE Director | Conversion | +14,485,597 | $0.02 | $352K | 16,467,403 |
| 2013-09-10 | NARINE JEENARINE Director | Conversion · Series E Confertible Preferred Stock | −1,600 | 0 | ||
| 2013-09-10 | NIGALAYE ASHOK G Scief Scientific Officer | Conversion | +19,753,086 | $0.02 | $480K | 22,455,550 |
Page 13 of 18 · 356 trades